ID   ADRB2_RAT               Reviewed;         418 AA.
AC   P10608; Q6LCR3;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   02-OCT-2024, entry version 185.
DE   RecName: Full=Beta-2 adrenergic receptor;
DE   AltName: Full=Beta-2 adrenoreceptor;
DE            Short=Beta-2 adrenoceptor;
GN   Name=Adrb2; Synonyms=Adrb2r;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2825184; DOI=10.1073/pnas.84.23.8296;
RA   Gocayne J.D., Robinson D.A., Fitzgerald M.G., Chung F.-Z., Kerlavage A.R.,
RA   Lentes K.-U., Lai J., Wang C.-D., Fraser C.M., Venter J.C.;
RT   "Primary structure of rat cardiac beta-adrenergic and muscarinic
RT   cholinergic receptors obtained by automated DNA sequence analysis: further
RT   evidence for a multigene family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:8296-8300(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=2155412; DOI=10.1093/nar/18.3.682;
RA   Buckland P.R., Hill R.M., Tidmarsh S.F., McGuffin P.;
RT   "Primary structure of the rat beta-2 adrenergic receptor gene.";
RL   Nucleic Acids Res. 18:682-682(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=7590294; DOI=10.1016/0378-1119(95)00357-c;
RA   Jiang L., Kunos G.;
RT   "Sequence of the 5' regulatory domain of the gene encoding the rat beta 2-
RT   adrenergic receptor.";
RL   Gene 163:331-332(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-23.
RX   PubMed=8597598; DOI=10.1016/0167-4781(95)00227-8;
RA   McGraw D.W., Jacobi S.E., Hiller F.C., Cornett L.E.;
RT   "Structural and functional analysis of the 5'-flanking region of the rat
RT   beta 2-adrenergic receptor gene.";
RL   Biochim. Biophys. Acta 1305:135-138(1996).
RN   [5]
RP   UBIQUITINATION.
RX   PubMed=23166351; DOI=10.1083/jcb.201208192;
RA   Han S.O., Xiao K., Kim J., Wu J.H., Wisler J.W., Nakamura N.,
RA   Freedman N.J., Shenoy S.K.;
RT   "MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound
RT   beta(2)-adrenergic receptors.";
RL   J. Cell Biol. 199:817-830(2012).
CC   -!- FUNCTION: Beta-adrenergic receptors mediate the catecholamine-induced
CC       activation of adenylate cyclase through the action of G proteins. The
CC       beta-2-adrenergic receptor binds epinephrine with an approximately 30-
CC       fold greater affinity than it does norepinephrine.
CC       {ECO:0000250|UniProtKB:P07550}.
CC   -!- SUBUNIT: Binds NHERF1 and GPRASP1. Interacts with ARRB1 and ARRB2.
CC       Interacts with SRC (By similarity). Interacts with USP20 and USP33 (By
CC       similarity). Interacts with VHL; the interaction, which is increased on
CC       hydroxylation of ADRB2, ubiquitinates ADRB2 leading to its degradation.
CC       Interacts with EGLN3; the interaction hydroxylates ADRB2 facilitating
CC       VHL-E3 ligase-mediated ubiquitination. Interacts (via PDZ-binding
CC       motif) with SNX27 (via PDZ domain); the interaction is required when
CC       endocytosed to prevent degradation in lysosomes and promote recycling
CC       to the plasma membrane. Interacts with CNIH4. Interacts with ARRDC3.
CC       Interacts with NEDD4 (By similarity). Interacts with MARCHF2 (By
CC       similarity). {ECO:0000250|UniProtKB:P07550}.
CC   -!- INTERACTION:
CC       P10608; P31016: Dlg4; NbExp=2; IntAct=EBI-7090342, EBI-375655;
CC       P10608; P19490: Gria1; NbExp=3; IntAct=EBI-7090342, EBI-371642;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P07550};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P07550}. Early
CC       endosome {ECO:0000250|UniProtKB:P07550}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:P07550}. Note=Colocalizes with VHL at the cell
CC       membrane. Activated receptors are internalized into endosomes prior to
CC       their degradation in lysosomes. Activated receptors are also detected
CC       within the Golgi apparatus. {ECO:0000250|UniProtKB:P07550}.
CC   -!- PTM: Palmitoylated; may reduce accessibility of Ser-345 and Ser-346 by
CC       anchoring Cys-341 to the plasma membrane. Agonist stimulation promotes
CC       depalmitoylation and further allows Ser-345 and Ser-346 phosphorylation
CC       (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated by PKA and BARK upon agonist stimulation, which
CC       mediates homologous desensitization of the receptor. PKA-mediated
CC       phosphorylation seems to facilitate phosphorylation by BARK.
CC   -!- PTM: Phosphorylation of Tyr-141 is induced by insulin and leads to
CC       supersensitization of the receptor. {ECO:0000250}.
CC   -!- PTM: Polyubiquitinated (PubMed:23166351). Agonist-induced
CC       ubiquitination leads to sort internalized receptors to the lysosomes
CC       for degradation (PubMed:23166351). Deubiquitination by USP20 and USP33,
CC       leads to ADRB2 recycling and resensitization after prolonged agonist
CC       stimulation. USP20 and USP33 are constitutively associated and are
CC       dissociated immediately after agonist stimulation. Ubiquitination by
CC       the VHL-E3 ligase complex is oxygen-dependent (By similarity).
CC       {ECO:0000250, ECO:0000269|PubMed:23166351}.
CC   -!- PTM: Hydroxylation by EGLN3 occurs only under normoxia and increases
CC       the interaction with VHL and the subsequent ubiquitination and
CC       degradation of ADRB2. {ECO:0000250}.
CC   -!- PTM: Palmitoylated. Mainly palmitoylated at Cys-341. Palmitoylation may
CC       reduce accessibility of phosphorylation sites by anchoring the receptor
CC       to the plasma membrane. Agonist stimulation promotes depalmitoylation
CC       and further allows Ser-345 and Ser-346 phosphorylation. Also undergoes
CC       transient, ligand-induced palmitoylation at Cys-265 probably by ZDHHC9,
CC       ZDHHC14 and ZDHHC18 within the Golgi. Palmitoylation at Cys-265
CC       requires phosphorylation by PKA and receptor internalization and
CC       stabilizes the receptor. Could be depalmitoylated by LYPLA1 at the
CC       plasma membrane. {ECO:0000250|UniProtKB:P07550}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       Adrenergic receptor subfamily. ADRB2 sub-subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J03024; AAA40675.1; -; mRNA.
DR   EMBL; X17607; CAA35609.1; -; Genomic_DNA.
DR   EMBL; L39264; AAA89068.1; -; Genomic_DNA.
DR   EMBL; U35448; AAC52449.1; -; Genomic_DNA.
DR   PIR; S10855; S10855.
DR   AlphaFoldDB; P10608; -.
DR   SMR; P10608; -.
DR   CORUM; P10608; -.
DR   IntAct; P10608; 5.
DR   MINT; P10608; -.
DR   STRING; 10116.ENSRNOP00000026098; -.
DR   BindingDB; P10608; -.
DR   ChEMBL; CHEMBL3754; -.
DR   DrugCentral; P10608; -.
DR   GuidetoPHARMACOLOGY; 29; -.
DR   GlyCosmos; P10608; 2 sites, No reported glycans.
DR   GlyGen; P10608; 2 sites.
DR   iPTMnet; P10608; -.
DR   PhosphoSitePlus; P10608; -.
DR   PaxDb; 10116-ENSRNOP00000026098; -.
DR   UCSC; RGD:2060; rat.
DR   AGR; RGD:2060; -.
DR   RGD; 2060; Adrb2.
DR   eggNOG; KOG3656; Eukaryota.
DR   InParanoid; P10608; -.
DR   PhylomeDB; P10608; -.
DR   Reactome; R-RNO-390696; Adrenoceptors.
DR   Reactome; R-RNO-418555; G alpha (s) signalling events.
DR   Reactome; R-RNO-5689880; Ub-specific processing proteases.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   PRO; PR:P10608; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0005901; C:caveola; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:RGD.
DR   GO; GO:0098992; C:neuronal dense core vesicle; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0042383; C:sarcolemma; IDA:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO.
DR   GO; GO:0008179; F:adenylate cyclase binding; ISO:RGD.
DR   GO; GO:0001540; F:amyloid-beta binding; ISO:RGD.
DR   GO; GO:0031713; F:B2 bradykinin receptor binding; IPI:RGD.
DR   GO; GO:0004941; F:beta2-adrenergic receptor activity; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0051379; F:epinephrine binding; TAS:RGD.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0051380; F:norepinephrine binding; ISO:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; TAS:RGD.
DR   GO; GO:0015459; F:potassium channel regulator activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IPI:ARUK-UCL.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0090722; F:receptor-receptor interaction; IPI:ARUK-UCL.
DR   GO; GO:0071880; P:adenylate cyclase-activating adrenergic receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0071875; P:adrenergic receptor signaling pathway; ISO:RGD.
DR   GO; GO:0008306; P:associative learning; IDA:RGD.
DR   GO; GO:0045453; P:bone resorption; ISO:RGD.
DR   GO; GO:0050873; P:brown fat cell differentiation; ISO:RGD.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:RGD.
DR   GO; GO:0002086; P:diaphragm contraction; IDA:RGD.
DR   GO; GO:0002024; P:diet induced thermogenesis; ISO:RGD.
DR   GO; GO:0044849; P:estrous cycle; IEP:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; IMP:RGD.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0031649; P:heat generation; ISO:RGD.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0097421; P:liver regeneration; IEP:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IMP:RGD.
DR   GO; GO:0045744; P:negative regulation of G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0040015; P:negative regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0030279; P:negative regulation of ossification; IMP:RGD.
DR   GO; GO:0045986; P:negative regulation of smooth muscle contraction; ISO:RGD.
DR   GO; GO:0035811; P:negative regulation of urine volume; IMP:RGD.
DR   GO; GO:0002025; P:norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:1901098; P:positive regulation of autophagosome maturation; ISS:GO_Central.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; ISO:RGD.
DR   GO; GO:1905665; P:positive regulation of calcium ion import across plasma membrane; IDA:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:1904504; P:positive regulation of lipophagy; ISS:GO_Central.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0061885; P:positive regulation of mini excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0043268; P:positive regulation of potassium ion transport; IDA:RGD.
DR   GO; GO:0010739; P:positive regulation of protein kinase A signaling; ISO:RGD.
DR   GO; GO:0048633; P:positive regulation of skeletal muscle tissue growth; IMP:RGD.
DR   GO; GO:0010765; P:positive regulation of sodium ion transport; IDA:RGD.
DR   GO; GO:0003059; P:positive regulation of the force of heart contraction by epinephrine; IDA:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; ISO:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IDA:RGD.
DR   GO; GO:0002028; P:regulation of sodium ion transport; ISO:RGD.
DR   GO; GO:0001993; P:regulation of systemic arterial blood pressure by norepinephrine-epinephrine; ISO:RGD.
DR   GO; GO:0071869; P:response to catecholamine; IDA:RGD.
DR   GO; GO:0009409; P:response to cold; ISO:RGD.
DR   GO; GO:0071548; P:response to dexamethasone; IEP:RGD.
DR   GO; GO:0043627; P:response to estrogen; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0071867; P:response to monoamine; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0033574; P:response to testosterone; IEP:RGD.
DR   GO; GO:0006939; P:smooth muscle contraction; ISO:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IMP:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0042311; P:vasodilation; IDA:RGD.
DR   CDD; cd15957; 7tmA_Beta2_AR; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR002233; ADR_fam.
DR   InterPro; IPR000332; ADRB2_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24248; ADRENERGIC RECEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR; 1.
DR   PANTHER; PTHR24248:SF21; BETA-2 ADRENERGIC RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01103; ADRENERGICR.
DR   PRINTS; PR00562; ADRENRGCB2AR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; Endosome; G-protein coupled receptor;
KW   Glycoprotein; Golgi apparatus; Hydroxylation; Lipoprotein; Membrane;
KW   Palmitate; Phosphoprotein; Receptor; Reference proteome; Transducer;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..418
FT                   /note="Beta-2 adrenergic receptor"
FT                   /id="PRO_0000069136"
FT   TOPO_DOM        1..34
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        35..58
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        59..71
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        72..95
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        96..106
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        107..129
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        130..150
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        151..174
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        175..196
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        197..220
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        221..274
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        275..298
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        299..305
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        306..329
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        330..418
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           415..418
FT                   /note="PDZ-binding"
FT   MOD_RES         141
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P07550"
FT   MOD_RES         246
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P07550"
FT   MOD_RES         261
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         262
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         345
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P07550"
FT   MOD_RES         346
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P07550"
FT   MOD_RES         355
FT                   /note="Phosphoserine; by BARK"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         356
FT                   /note="Phosphoserine; by BARK"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         387
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         400
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   LIPID           265
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P07550"
FT   LIPID           341
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P07550"
FT   CARBOHYD        6
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305"
FT   CARBOHYD        15
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305"
FT   DISULFID        106..191
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        184..190
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   CONFLICT        262
FT                   /note="S -> F (in Ref. 2; AAA89068)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        334
FT                   /note="I -> Y (in Ref. 2; AAA89068)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   418 AA;  46891 MW;  907B2882AFC02AC5 CRC64;
     MEPHGNDSDF LLAPNGSRAP GHDITQERDE AWVVGMAILM SVIVLAIVFG NVLVITAIAK
     FERLQTVTNY FITSLACADL VMGLAVVPFG ASHILMKMWN FGNFWCEFWT SIDVLCVTAS
     IETLCVIAVD RYVAITSPFK YQSLLTKNKA RVVILMVWIV SGLTSFLPIQ MHWYRATHKQ
     AIDCYAKETC CDFFTNQAYA IASSIVSFYV PLVVMVFVYS RVFQVAKRQL QKIDKSEGRF
     HAQNLSQVEQ DGRSGHGLRS SSKFCLKEHK ALKTLGIIMG TFTLCWLPFF IVNIVHVIRA
     NLIPKEVYIL LNWLGYVNSA FNPLIYCRSP DFRIAFQELL CLRRSSSKTY GNGYSSNSNG
     RTDYTGEQSA YQLGQEKENE LLCEEAPGME GFVNCQGTVP SLSIDSQGRN CNTNDSPL
//
